PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK. All pages complete
Table of Contents
Table of Contents Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and Chapter 11: Drug Calculations
Ethical Considerations Chapter 12: Fluid Volume and
Chapter 02: Pharmacokinetics, Electrolytes
Pharmacodynamics, and Chapter 13: Vitamin and Mineral
Pharmacogenetics Replacement
Chapter 03: Cultural Considerations Chapter 14: Nutritional Support
Chapter 04: Complementary and Chapter 15: Adrenergic Agonists and
Alternative Therapies Antagonists
Chapter 05: Pediatric Considerations Chapter 16: Cholinergic Agonists and
Chapter 06: Geriatric Considerations Antagonists
Chapter 07: Drugs in Substance Use Chapter 17: Stimulants
Disorder Chapter 18: Depressants
Chapter 08: The Nursing Process and Chapter 19: Antiseizure Drugs
Patient-Centered Care Chapter 20: Drugs for Parkinsonism and
Chapter 09: Safety and Quality Alzheimer's Disease
Chapter 10: Drug Administration Chapter 21: Drugs for Neuromuscular
1
,Disorders and Muscle Spasms Anthelmintic
Chapter 22: Antipsychotics and Chapter 29: HIV- and AIDS-Related
Anxiolytics Drugs
Chapter 23: Antidepressants and Mood Chapter 30: Transplant Drugs
Stabilizers Chapter 31: Vaccines
Chapter 24: Antiinflammatories Chapter 32: Anticancer Drugs
Chapter 25: Analgesics Chapter 33: Targeted Therapies to Treat
Chapter 26: Antibacterials Cancer
Chapter 27: Antituberculars, Antifungals, Chapter 34: Biologic Response
and Antivirals Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear Disorders
Chapter 45: Dermatologic Disorders
Chapter 46: Pituitary, Thyroid,
Parathyroid, and Adrenal Disorders
Chapter 47: Antidiabetics
Chapter 48: Urinary Disorders
Chapter 49: Pregnancy and Preterm
Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and Newborn
Chapter 52: Women's Reproductive
Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
Emergency Drugs
2
,Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic
medicationmay be given.The patient asks the nurse what this means. What will the nurse tell
the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
3
, a. is a controlled substance.
4
Table of Contents
Table of Contents Chapter 28: Peptides, Antimalarial, and
Chapter 01: Drug Development and Chapter 11: Drug Calculations
Ethical Considerations Chapter 12: Fluid Volume and
Chapter 02: Pharmacokinetics, Electrolytes
Pharmacodynamics, and Chapter 13: Vitamin and Mineral
Pharmacogenetics Replacement
Chapter 03: Cultural Considerations Chapter 14: Nutritional Support
Chapter 04: Complementary and Chapter 15: Adrenergic Agonists and
Alternative Therapies Antagonists
Chapter 05: Pediatric Considerations Chapter 16: Cholinergic Agonists and
Chapter 06: Geriatric Considerations Antagonists
Chapter 07: Drugs in Substance Use Chapter 17: Stimulants
Disorder Chapter 18: Depressants
Chapter 08: The Nursing Process and Chapter 19: Antiseizure Drugs
Patient-Centered Care Chapter 20: Drugs for Parkinsonism and
Chapter 09: Safety and Quality Alzheimer's Disease
Chapter 10: Drug Administration Chapter 21: Drugs for Neuromuscular
1
,Disorders and Muscle Spasms Anthelmintic
Chapter 22: Antipsychotics and Chapter 29: HIV- and AIDS-Related
Anxiolytics Drugs
Chapter 23: Antidepressants and Mood Chapter 30: Transplant Drugs
Stabilizers Chapter 31: Vaccines
Chapter 24: Antiinflammatories Chapter 32: Anticancer Drugs
Chapter 25: Analgesics Chapter 33: Targeted Therapies to Treat
Chapter 26: Antibacterials Cancer
Chapter 27: Antituberculars, Antifungals, Chapter 34: Biologic Response
and Antivirals Modifiers
Chapter 35: Upper Respiratory
Disorders
Chapter 36: Lower Respiratory
Disorders
Chapter 37: Cardiac Glycosides,
Antianginals, and Antidysrhythmics
Chapter 38: Diuretics
Chapter 39: Antihypertensive
Chapter 40: Anticoagulants,
Antiplatelets, and Thrombolytics
Chapter 41: Antihyperlipidemics and
Peripheral Vasodilators
Chapter 42: Gastrointestinal Tract
Disorders
Chapter 43: Antiulcer Drugs
Chapter 44: Eye and Ear Disorders
Chapter 45: Dermatologic Disorders
Chapter 46: Pituitary, Thyroid,
Parathyroid, and Adrenal Disorders
Chapter 47: Antidiabetics
Chapter 48: Urinary Disorders
Chapter 49: Pregnancy and Preterm
Labor
Chapter 50: Labor, Delivery, and
Postpartum
Chapter 51: Neonatal and Newborn
Chapter 52: Women's Reproductive
Health
Chapter 53: Men's Reproductive Health
Chapter 54: Sexually Transmitted
Infections
Chapter 55: Adult and Pediatric
Emergency Drugs
2
,Chapter 01: Drug Development and Ethical Considerations
MULTIPLE CHOICE
1. The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a Single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the vial.
b. Keep the remaining amount in the patient’s drawer to give at the next dose.
c. Record the amount unused in the patient’s medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting a
portion of a drug, another nurse should observe and cosign that a drug was wasted.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic medication will have a name that
a. is a registered trademark.
b. is always capitalized.
c. describes the drugs chemical structure.
d. is non-proprietary.
ANS: D
The generic name is the official, non-proprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical structure
of the drug.
DIF: COGNITIVE LEVEL: Understanding (Comprehension)
TOP: NURSING PROCESS: N/A
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
3. A patient receives a prescription on which the provider has noted that a generic
medicationmay be given.The patient asks the nurse what this means. What will the nurse tell
the patientabout generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are identical to proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the brand-
name drug. They tend to be less expensive because manufacturers of these drugs do not have
to do the extensive testing required of brand-name drugs before marketing. They are not
identical to brand-name drugs and often have different inert ingredients.
DIF: COGNITIVE LEVEL: Applying (Application)
TOP: NURSING PROCESS: Nursing Intervention: Patient Teaching
MSC: NCLEX: Management of Client Care
4. The nurse reviews information about a drug and notes the initials USP after the drugs official
name. The nurse understands that this designation indicates the drug
3
, a. is a controlled substance.
4
